Cargando…
Comparative efficacy and safety of glucagon-like peptide 1 receptor agonists for the treatment of type 2 diabetes: A network meta-analysis
This study aimed to evaluate the clinical efficacy and safety of 4 weekly formulations of glucagon-like peptide 1 receptor agonists (GLP-1RAs) on glycemic control, including glycemic control, by using a network meta-analysis (NMA). METHODS: PubMed, EMBASE, and Cochrane Library Central Register of Co...
Autores principales: | Chen, Han, Li, Xin-Zhu, Chen, Jia-Qing, Ren, Tian-Shu, Zhang, Ying-Shi, Wang, Yi-Nuo, Zhao, Qing-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328610/ https://www.ncbi.nlm.nih.gov/pubmed/37417602 http://dx.doi.org/10.1097/MD.0000000000034122 |
Ejemplares similares
-
Maturity-Onset diabetes of the young type 5 treated with the glucagon-like peptide-1 receptor agonist: A case report
por: Terakawa, Aiko, et al.
Publicado: (2020) -
Effects of glucagon-like peptide 1 receptor agonists and sodium glucose cotransporter 2 inhibitors on major adverse cardiovascular events in type 2 diabetes by race, ethnicity, and region: A meta-analysis
por: Qiu, Mei, et al.
Publicado: (2020) -
Effect of long-acting versus short-acting glucagon-like peptide-1 receptor agonists on improving body weight and related metabolic parameters in type 2 diabetes: A head-to-head meta-analysis
por: Yuan, Xia, et al.
Publicado: (2023) -
Protective Role of Glucagon-Like Peptide-1 Against High-Glucose-Induced Endothelial Oxidative Damage
por: Guo, Lixin, et al.
Publicado: (2015) -
Safety and efficacy of Prunella vulgaris preparation in adjuvant treatment of thyroid nodules: A meta-analysis
por: Han, Qing, et al.
Publicado: (2021)